Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jun 30, 2014

Cancer Treatment Gets Personal

As therapeutics become more precision targeted, the practice of clinical medicine is moving away from one size fits all, to one size fits one.

Cancer Treatment Gets Personal

An increasing flow of cancer therapeutics and diagnostics is allowing clinicians to more accurately target therapies to treat a broad range of cancer subtypes. [Alexander Raths-Fotolia.com]

  • As recently as ten years ago, just after completion of the Human Genome Project, the concept of a personalized approach to cancer treatment was ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »